From Allstar to Insuman, Sanofi Expands ‘Make In India’ Plans
This article was originally published in PharmAsia News
Executive Summary
The French drug firm Sanofi is bullish on producing some of its products in India. It first acquired Shantha Biotechnics and it manufacturing capabilities in 2009 and later started making its pen devices locally, and is now setting up a large project to make the human insulin product Insuman.